Blue Jet Healthcare
Market cap ₹8,993 Cr
- P/E
- 32.34
- Day range
- ₹506.00 – ₹521.60
- 52-week range
- ₹325.00 – ₹647.80
- Volume
- 2.53 L
- Open
- ₹510.05
- Prev close
- ₹510.60
Latest results · Q2 FY27(standalone)Revenue ₹376 Cr+127.1%Profit ₹103 Cr+96.6%Margin 27.3%YoY vs the same quarter last year
1 red flag to read up on
- medium
Promoter holding falling
73.15%, down 6.66 pts since 2025-12-31 · 30 Sept 2026
From NSE and BSE filings. A flag is a reason to read the filing, not a rating.
BLUEJET in NSE indices and F&O
Research profile
Composite 48 / 100Factor percentiles
Derived metrics
- Earn. yield
- 3.1%
- Graham no.
- ₹198.56
- vs Graham
- -61.7%
- ROE ÷ P/B
- 4.5%
- 12-1 mom.
- -11.7%
- Return / vol
- -0.26
- Magic Formula
- #161
- FCF yield
- 1.3%
Appears in 13 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 68 in Pharma| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Sun PharmaSUNPHARMA | ₹4.49 L Cr | 40.95 | 5.03 | 14.8% | 21.0% | 29.0% | 0.04 | +11.9% |
| Divi's LaboratoriesDIVISLAB | ₹2.93 L Cr | 87.19 | 16.88 | 16.2% | 22.0% | 43.0% | 0.00 | +35.4% |
| Torrent PharmaTORNTPHARM | ₹1.75 L Cr | 77.88 | 9.67 | 26.8% | 15.0% | 33.0% | 0.77 | +50.8% |
| Apollo HospitalsAPOLLOHOSP | ₹1.27 L Cr | 56.40 | 11.55 | 22.6% | 17.0% | 16.0% | 0.77 | +23.0% |
| Laurus LabsLAURUSLABS | ₹1.25 L Cr | 93.72 | 19.82 | 18.2% | 18.0% | 34.0% | 0.43 | +33.5% |
| Zydus LifesciencesZYDUSLIFE | ₹1.20 L Cr | 28.72 | 4.32 | 20.1% | 21.0% | 24.0% | 0.50 | +29.2% |
| Dr. Reddy's LabsDRREDDY | ₹1.17 L Cr | 41.63 | 2.97 | 11.6% | 13.0% | 20.0% | 0.19 | -1.5% |
| Blue Jet HealthcareBLUEJET | ₹8,993 Cr | 32.34 | 4.45 | 19.9% | 26.0% | 32.0% | 0.02 | +127.9% |
| Sector median | ₹24,603 Cr | 43.68 | 5.46 | 15.1% | 17.0% | 24.0% | 0.17 | +22.7% |
Sector as classified in the tracked universe; medians use every tracked Pharma company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 1d agoHeadlines about Blue Jet Healthcare from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 34.4
- Price / Book
- 4.28
- ROE (FY26)
- 19.9%
- ROCE (latest year)
- 26%
- Dividend yield
- 0.23%
Moving averages (NSE)
- 20-day
- ₹515.91
- Price above
- 50-day
- ₹537.03
- Price below
- 200-day
- ₹491.17
- Price above
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- Public
- DII
- FII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date.
Financial statements
| Line item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 167 | 184 | 163 | 208 | 318 | 340 | 355 | 165 | 192 | 235 | 293 | 376 |
| YoY Sales growth | -1 | -15 | -9 | — | — | — | — | -21 | -40 | -31 | -17 | — |
| Expenses | 112 | 131 | 119 | 139 | 194 | 200 | 234 | 111 | 146 | 163 | 195 | 257 |
| Operating Profit | 55 | 53 | 44 | 69 | 124 | 140 | 121 | 55 | 47 | 71 | 98 | 119 |
| OPM % | 33% | 29% | 27% | 33% | 39% | 41% | 34% | 33% | 24% | 30% | 33% | 32% |
| Other Income | -3 | 9 | 9 | 12 | 13 | 12 | 8 | 24 | 13 | 23 | 15 | 26 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 0 | 1 | 1 | 1 |
| Depreciation | 8 | 8 | 3 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 7 | 7 |
| Profit before tax | 44 | 54 | 49 | 77 | 132 | 147 | 123 | 69 | 54 | 87 | 106 | 137 |
| Tax % | 27% | 27% | 24% | 24% | 25% | 25% | 26% | 24% | 25% | 26% | 26% | 25% |
| Net Profit | 32 | 40 | 38 | 58 | 99 | 110 | 91 | 52 | 40 | 64 | 78 | 103 |
| EPS in Rs | ₹1.85 | ₹2.29 | ₹2.18 | ₹3.36 | ₹5.71 | ₹6.35 | ₹5.26 | ₹3.01 | ₹2.32 | ₹3.71 | ₹4.51 | ₹5.42 |
From company filings, updated 19 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
+26 days since Mar 2021
-96 days since Mar 2021
-80 days since Mar 2021
+9 days since Mar 2021
+47 days since Mar 2021
Strengths, risks & growth
Incorporated in 1968, Blue Jet Healthcare (earlier called Jet Chemicals Pvt Ltd) is a pharmaceutical and healthcare ingredient & intermediate company and the first manufacturer of saccharin and its salts (artificial sweeteners) in India. [1]
Strengths
- Company is almost debt free.
- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 23.8%
Risks
None flagged by the checklist.
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- +14%
- 3 Years
- +10%
- TTM
- -7%
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- +12%
- 3 Years
- +15%
- TTM
- -19%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- —
- 3 Years
- +10%
- 1 Year
- -9%
Return on Equity
- 10 Years
- —
- 5 Years
- +26%
- 3 Years
- +24%
- Last Year
- +20%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 79.81% | 79.81% | 79.81% | 73.15% | -6.66 pp |
| FII | 1.14% | 0.89% | 0.40% | 0.81% | +0.41 pp |
| DII | 4.65% | 4.51% | 4.65% | 7.48% | +2.83 pp |
| Public | 14.41% | 14.80% | 15.14% | 18.56% | +3.42 pp |
Filed with NSE for Sept 2026: promoters 73.15%, public 26.85%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 4.10% (-1.08 pp)- Promoters73.2%
- Foreign institutions0.8%
- Mutual funds4.1%
- Insurance0.7%
- Other domestic institutions2.6%
- Retail10.0%
- Others8.6%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| ICICI Pru Healthcare Fund | 1.22% | 1.66% | -0.73 pp |
| ICICI Pru Value Fund | 0.67% | 0.11% | -0.02 pp |
| ICICI Pru Manufacturing Fund | 0.65% | 0.96% | -0.17 pp |
| UTI Small Cap Fund | 0.43% | 0.84% | -0.06 pp |
| UTI Healthcare Fund | 0.23% | 1.58% | +0.46 pp |
Scorecard
- Performance
- Low
- Valuation
- High
- Growth
- Low
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 292 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 46.4%
- Downside volatility
- 43.2%
- Worst 5% of days
- 4.8%
- Average of that tail
- 6.6%
- Max drawdown (1Y)
- 54.4%
- Below its peak
- 27.7%
Against the market
- Beta vs Nifty 50
- 1.45
- Correlation
- 0.42
- Relative strength (3M)
- -16.5%
- ATR (14)
- 4.5%
Return
- Return 1M
- -0.4%
- Return 3M
- -12.6%
- Return 6M
- +23.1%
- Return 1Y
- -12.1%
- vs 200-day average
- +5.6%
Momentum
- RSI (14)
- 47.4
- MACD histogram
- 0.84
- Stochastic %K
- 23.8
- ADX (14)
- 28.6
- +DI / −DI
- 22.9 / 19.7
- Money flow index
- 70.4
Participation
- Delivery (20d avg)
- 49.8%
- vs its 60-day baseline
- -0.5 pts
- Volume vs 20-day
- -0.3σ
- Close vs day's VWAP
- +0.9%
- 52-week position
- 49 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
No F-Score: it needs two reporting periods a year apart that carry both an income statement and a balance sheet, and this company's filings do not yet line up that way. The ratios below need only the one period and are unaffected.
- Free cash flow
- ₹115 Cr
- FCF yield
- 1.3%
- Net debt
- -₹38 Cr
- Net debt / equity
- -0.02
- EV / sales
- 8.17
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Corporate actions
- dividend₹1.20
Dividend - Rs 1.20 Per Share
11 Sept 2026ex-date - dividend₹1.20
Dividend - Rs 1.20 Per Share
19 Sept 2025ex-date - dividendNot available — not reported in this filing
Dividend - Re 1 Per Share
17 Sept 2024ex-date - otherNot available — not reported in this filing
Annual General Meeting
17 Sept 2024ex-date
Company announcements
Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026
Intimation of closure of trading window
Scrutinizer's Report and voting results for AGM
Outcome of 58th Annual General Meeting of the Company
Intimation of Newspaper Publication of information regarding 58th Annual General Meeting through VC/Other Audio Visual Means
BRSR for FY 2025-26
Notice of Annual General Meeting scheduled to be held on September 21, 2026
Annual Report pertaining to FY 2025-26
Intimation of Newspaper Publication regarding 58th Annual General Meeting through Video Conferencing/Other Audio Visual Means to be held on 21st September, 2026.
Transcript for Earnings call for the Financials Results for the quarter ended June 30, 2026
Publication of Unaudited Standalone Financial results of the Company for the Quarter ended June 30, 2026
Submission of Audio recording of earnings conference call pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Investor Presentation for Financial Results for the quarter ended June 30, 2026
As per attached file
As per attached file
Filed with BSE (scrip 544009); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Nov 2026TranscriptSlidesRecording
- Aug 2026TranscriptSlidesRecording
- May 2026TranscriptSlidesRecording
- Feb 2026TranscriptSlidesRecording
- Nov 2025TranscriptSlidesRecording
- Jul 2025TranscriptSlidesRecording
Credit ratings
- Rating update · 26 Oct from care
- Rating update · 16 Dec 2025 from care
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 5 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Blue Jet Healthcare: common questions
Answered from the figures on this page.